Endocrinology and Metabolism

404 soru

Tüm türler404 Çoktan seçmeli210 Eşleştirme92 Sıralama102

A $22$ -year-old woman with a history of type $1$ diabetes mellitus is brought to the emergency department by her roommate due to severe lethargy, nausea, and diffuse abdominal pain for the past day. She has been unable to tolerate oral intake following a recent upper respiratory infection. Her temperature is $37.8^\circ\text{C}$ ( $100.0^\circ\text{F}$ ), blood pressure is $88/54\text{ mmHg}$ , pulse is $128/\text{min}$ , and respirations are $28/\text{min}$ with deep, sighing breaths. The patient appears clinically dehydrated with dry mucous membranes. Capillary blood glucose is $610\text{ mg/dL}$ . Initial laboratory studies are as follows:

Serum sodium: $132\text{ mEq/L}$
Serum potassium: $3.1\text{ mEq/L}$
Serum chloride: $98\text{ mEq/L}$
Serum bicarbonate: $10\text{ mEq/L}$

Arterial blood gas shows a pH of $7.12$ . Urinalysis is strongly positive for ketones.

Arrange the following management steps in the most appropriate chronological sequence for this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence of management is: intravenous fluid resuscitation, followed by potassium chloride repletion, then initiation of intravenous insulin, later addition of dextrose to IV fluids, and finally transitioning to subcutaneous insulin.

The optimal management of diabetic ketoacidosis involves a highly structured algorithmic approach. Step 1: Intravenous normal saline is the most urgent intervention to correct profound volume depletion and shock. Step 2: Because this patient has a serum potassium level < 3.3 mEq/L, insulin must be withheld and potassium chloride administered first. Step 3: Once potassium is safely ≥ 3.3 mEq/L, intravenous regular insulin is started to suppress ketogenesis and resolve the acidosis. Step 4: As insulin lowers the blood glucose, 5% dextrose must be added to the IV fluids once glucose drops to ~200 mg/dL to prevent hypoglycemia, as the insulin infusion must continue until the anion gap closes. Step 5: After the anion gap closes and the patient can eat, an overlap with subcutaneous insulin is performed before discontinuing the IV insulin.

Adım Adım Çözüm

Initiate intravenous fluid resuscitation with 0.9% normal saline.

Restores intravascular volume and improves renal perfusion.

The patient is hypotensive and severely dehydrated from osmotic diuresis; volume expansion is the most urgent initial step in diabetic ketoacidosis (DKA) management.

Administer intravenous potassium chloride.

Corrects the severe total body potassium deficit.

The initial serum potassium is critically low (< 3.3 mEq/L). Administering insulin first would drive potassium intracellularly, precipitating life-threatening arrhythmias.

Initiate continuous intravenous regular insulin infusion.

Halts lipolysis, ketogenesis, and gluconeogenesis.

Once potassium is confirmed to be ≥ 3.3 mEq/L, insulin is started to reverse the ketoacidosis and close the anion gap.

Add 5% dextrose to the intravenous fluids.

Prevents iatrogenic hypoglycemia while continuing insulin therapy.

When the serum glucose falls below 200-250 mg/dL, dextrose must be added because insulin is still required to fully clear the ketones and close the anion gap.

Transition to a subcutaneous basal-bolus insulin regimen.

Maintains glycemic control outside the acute setting.

Once the anion gap is closed, the patient is hemodynamically stable, and oral intake is tolerated, IV insulin can be overlapped and transitioned to subcutaneous insulin.

Anahtar Kavram

Stepwise management of Diabetic Ketoacidosis (DKA) with severe initial hypokalemia

Tahmini Süre:1m 30s

Soru 2Soru →

A 65-year-old man is brought to the emergency department by his family due to a 2-day history of worsening confusion, extreme thirst, and frequent urination. He has a 12-year history of type 2 diabetes mellitus and takes metformin and sitagliptin. He recently recovered from a mild urinary tract infection.

Vital signs show a temperature of $37.1^\circ\text{C}$ ( $98.8^\circ\text{F}$ ), heart rate of $112\text{/min}$ , blood pressure of $100/60\text{ mmHg}$ , and respiratory rate of $18\text{/min}$ .

Physical examination reveals dry mucous membranes and poor skin turgor. He is somnolent but arousable.

Laboratory evaluation shows:

Laboratory Test	Result
Serum sodium	$132\text{ mEq/L}$
Serum potassium	$3.1\text{ mEq/L}$
Serum chloride	$98\text{ mEq/L}$
Serum bicarbonate	$22\text{ mEq/L}$
Blood urea nitrogen	$48\text{ mg/dL}$
Serum creatinine	$1.9\text{ mg/dL}$
Serum glucose	$940\text{ mg/dL}$
Serum ketones	Small
Serum osmolality	$350\text{ mOsm/kg H}_2\text{O}$

An intravenous line is established, and rapid fluid resuscitation with $0.9\%$ sodium chloride is initiated. Which of the following is the most appropriate next step in the pharmacological management of this patient?

Addition of intravenous potassium chloride

Initiation of a continuous intravenous regular insulin infusion

Administration of intravenous sodium bicarbonate

Switching intravenous fluids to 0.45% sodium chloride

Initiation of broad-spectrum intravenous antibiotics

Cevabı ve açıklamayı göster

Cevap: Addition of intravenous potassium chloride

Cevap

The correct answer is the addition of intravenous potassium chloride.

This patient is presenting with a hyperosmolar hyperglycemic state (HHS). The initial step in management is aggressive intravenous fluid resuscitation with

0.9\%

normal saline, which has already been initiated. The next critical step is to evaluate the serum potassium level before starting insulin therapy. Patients with HHS typically have massive total body potassium depletion due to profound osmotic diuresis. Insulin administration drives both glucose and potassium into the cells, which can acutely lower serum potassium levels and precipitate life-threatening cardiac arrhythmias and respiratory muscle weakness. According to standardized protocols, if the serum potassium is

< 3.3\text{ mEq/L}

, insulin must be held, and intravenous potassium chloride must be administered (usually

20-30\text{ mEq/hr}

) until the potassium level rises to

\ge 3.3\text{ mEq/L}

. Only then is it safe to initiate an insulin infusion.

Adım Adım Çözüm

Analyze the patient's clinical presentation and laboratory results.

The patient has extreme hyperglycemia (

940\text{ mg/dL}

), high serum osmolality (

350\text{ mOsm/kg}

), and altered mental status with minimal ketones/acidosis (bicarbonate

22\text{ mEq/L}

), confirming a diagnosis of hyperosmolar hyperglycemic state (HHS).

Identifying the specific metabolic syndrome is necessary to apply the correct treatment algorithm.

Evaluate the current management and identify the next physiological priority.

Fluid resuscitation with

0.9\%

sodium chloride has appropriately been started. The next priority is addressing the serum potassium level of

3.1\text{ mEq/L}

before giving insulin.

In HHS and DKA, mortality is often driven by metabolic shifts during treatment rather than the hyperglycemia itself.

Apply the treatment algorithm for HHS regarding potassium management.

Because insulin shifts potassium intracellularly, administering insulin when serum potassium is

< 3.3\text{ mEq/L}

will cause severe hypokalemia. Therefore, insulin must be withheld and intravenous potassium chloride administered first.

Preventing life-threatening cardiac arrhythmias and respiratory muscle weakness is the immediate priority.

Anahtar Kavram

In the management of hyperosmolar hyperglycemic state (HHS) or diabetic ketoacidosis (DKA), if the serum potassium level is less than 3.3 mEq/L, insulin therapy is strictly contraindicated and must be held until intravenous potassium chloride brings the level above 3.3 mEq/L.

Tahmini Süre:1m 30s

Soru 3Soru →

An evaluation is requested for a 68-year-old man who has developed severe anxiety, worsening palpitations, and a $4.5\text{-kg}$ ( $10\text{-lb}$ ) unintentional weight loss over the past four weeks. He has a complex cardiovascular history including ischemic cardiomyopathy and recurrent ventricular tachycardia, which is currently managed with metoprolol, lisinopril, aspirin, and amiodarone. The amiodarone was initiated two years ago. Vital signs show a pulse of $112\text{/min}$ with an irregular rhythm, and blood pressure is $138/82\text{ mmHg}$ . Physical examination reveals hyperreflexia, warm and moist skin, and a bilateral fine hand tremor. A non-tender, symmetrically enlarged thyroid gland is appreciated on palpation.

Recent laboratory results are as follows:

Laboratory Test	Result	Reference Range
Thyroid-stimulating hormone (TSH)	$0.02\text{ mIU/L}$	$0.4-4.0\text{ mIU/L}$
Free thyroxine (T4)	$3.8\text{ ng/dL}$	$0.9-1.7\text{ ng/dL}$
Total triiodothyronine (T3)	$210\text{ ng/dL}$	$80-200\text{ ng/dL}$

Which of the following is the most appropriate next step in the evaluation of this patient's current condition?

Color flow Doppler ultrasonography of the thyroid

Radioactive iodine uptake (RAIU) scan

Immediate discontinuation of amiodarone

Initiation of methimazole therapy

Measurement of serum thyroglobulin concentration

Cevabı ve açıklamayı göster

Cevap: Color flow Doppler ultrasonography of the thyroid

Cevap

Color flow Doppler ultrasonography of the thyroid

The correct response is color flow Doppler ultrasonography of the thyroid. This patient's suppressed TSH and elevated thyroid hormones confirm thyrotoxicosis, and his medication history strongly points to amiodarone-induced thyrotoxicosis (AIT). Amiodarone can cause thyrotoxicosis through two distinct mechanisms. Type 1 AIT occurs in patients with underlying thyroid pathology (e.g., latent Graves disease or multinodular goiter) where the massive iodine load in amiodarone fuels excessive hormone synthesis (Jod-Basedow phenomenon). Type 2 AIT is a destructive thyroiditis caused by the direct toxic effect of amiodarone on follicular cells, leading to the release of preformed hormone. Differentiating these two is absolutely critical because management differs significantly: Type 1 requires synthesis inhibitors (methimazole), whereas Type 2 requires anti-inflammatory therapy (glucocorticoids). Because the massive iodine load of amiodarone renders standard radioactive iodine uptake (RAIU) scans useless (uptake will be suppressed in both types), color flow Doppler ultrasonography is the preferred initial diagnostic test. Type 1 AIT typically shows normal or increased vascularity, while Type 2 AIT demonstrates decreased or absent vascularity.

Adım Adım Çözüm

Analyze the patient's clinical presentation and laboratory findings.

The patient has signs of thyrotoxicosis (tremor, weight loss, palpitations, suppressed TSH, elevated Free T4 and T3) in the setting of chronic amiodarone use.

Establishing the biochemical diagnosis of thyrotoxicosis and identifying the likely offending pharmacologic agent is the necessary first step.

Recall the distinct pathophysiology of amiodarone-induced thyrotoxicosis (AIT).

AIT presents in two forms: Type 1 (hyperthyroidism due to underlying autonomous tissue exposed to iodine load) and Type 2 (destructive thyroiditis due to direct drug toxicity).

Differentiation is critical because the treatments are diametrically opposed: thionamides for Type 1 and glucocorticoids for Type 2.

Select the appropriate diagnostic modality to differentiate the subtypes.

Color flow Doppler ultrasonography is selected.

Standard nuclear medicine scans (RAIU) are invalid due to amiodarone's massive iodine content. Doppler ultrasound circumvents this by structurally evaluating blood flow (increased in Type 1, decreased in Type 2).

Anahtar Kavram

Differentiation of Amiodarone-Induced Thyrotoxicosis Subtypes

Soru 4Soru →

A 36-year-old woman is evaluated in the endocrinology clinic for a 9-month history of amenorrhea and bilateral milky nipple discharge. She has also experienced mild, dull frontal headaches over the past 3 months. She takes no medications, and a urine pregnancy test performed in the clinic is negative. Menarche occurred at age 13, and her menses were previously regular. Her body mass index (BMI) is $24 \text{ kg/m}^2$ . Vital signs are within normal limits. Physical examination confirms bilateral galactorrhea. Visual field testing by confrontation reveals intact peripheral vision in both eyes.

Laboratory studies show the following:
Prolactin: $68 \text{ ng/mL}$ (Normal: $4$ - $23 \text{ ng/mL}$ )
Thyroid-stimulating hormone (TSH): $1.8 \ \mu\text{U/mL}$ (Normal: $0.4$ - $4.2 \ \mu\text{U/mL}$ )
Free thyroxine (T4): $1.1 \text{ ng/dL}$ (Normal: $0.9$ - $1.7 \text{ ng/dL}$ )
Insulin-like growth factor-1 (IGF-1): $180 \text{ ng/mL}$ (within normal limits for age)
Morning cortisol: $14 \ \mu\text{g/dL}$ (Normal: $5$ - $25 \ \mu\text{g/dL}$ )

Magnetic resonance imaging (MRI) of the brain reveals a $1.8$ -cm homogeneous sellar mass with suprasellar extension. The mass is compressing the pituitary stalk and abutting the optic chiasm.

Which of the following is the most appropriate next step in the management of this patient?

Transsphenoidal surgical resection

Initiation of cabergoline therapy

Initiation of levothyroxine therapy

Serial observation with repeat MRI of the brain in 6 months

Intravenous hydrocortisone administration

Cevabı ve açıklamayı göster

Cevap: Transsphenoidal surgical resection

Cevap

Transsphenoidal surgical resection

The correct answer is transsphenoidal surgical resection because the patient has a clinically non-functioning pituitary macroadenoma causing symptomatic mass effect. While her prolactin is elevated, the level (

68 \text{ ng/mL}

) is far too low for a

1.8

-cm true prolactinoma, which typically secretes prolactin at levels

> 200 \text{ ng/mL}

. Instead, the mild hyperprolactinemia is due to the "stalk effect"—the large tumor compresses the pituitary stalk, disrupting the normal delivery of inhibitory dopamine from the hypothalamus to the lactotrophs. Because dopamine agonists (e.g., cabergoline) are ineffective at shrinking non-functioning adenomas, surgery is the treatment of choice to relieve headaches and prevent impending visual loss from optic chiasm compression.

Adım Adım Çözüm

Evaluate the clinical and laboratory presentation.

The patient has a

1.8

-cm pituitary mass with mildly elevated prolactin (

68 \text{ ng/mL}

) and normal thyroid, IGF-1, and cortisol levels.

Establishing the biochemical activity of the pituitary mass is essential for accurate diagnosis and management.

Correlate the tumor size with the prolactin level.

A true prolactinoma measuring

1.8 \text{ cm}

(a macroadenoma) would expectedly produce prolactin levels

> 200 \text{ ng/mL}

(often

> 1000 \text{ ng/mL}

). The level of

68 \text{ ng/mL}

is disproportionately low for the tumor size.

Tumor size in prolactinomas correlates directly with hormone secretion. A mismatch suggests a different etiology for the hyperprolactinemia.

Identify the mechanism of hyperprolactinemia.

The mild prolactin elevation is caused by the "stalk effect"—the

1.8

-cm non-functioning macroadenoma is compressing the pituitary stalk, blocking the delivery of inhibitory dopamine from the hypothalamus to the lactotrophs.

Understanding the stalk effect confirms the diagnosis of a clinically non-functioning pituitary adenoma rather than a prolactinoma.

Determine the appropriate management for the confirmed diagnosis.

Dopamine agonists do not reliably shrink non-functioning adenomas. Because the mass is large, abutting the optic chiasm, and causing headaches, surgical resection is required.

Surgical decompression is the definitive treatment for symptomatic non-functioning macroadenomas to relieve mass effect and preserve vision.

Anahtar Kavram

Discordance between a large pituitary mass size and a mildly elevated prolactin level (< 200 ng/mL) indicates a non-functioning adenoma causing stalk compression, which requires surgery, rather than a prolactinoma, which is treated medically.

Soru 5Soru →

Match each patient's clinical presentation and laboratory profile to the most likely underlying pathophysiologic mechanism.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

The clinical vignettes represent distinct mechanisms of calcium and phosphorus dysregulation: Humoral hypercalcemia of malignancy (PTHrP), Primary hyperparathyroidism (PTH overproduction), Familial hypocalciuric hypercalcemia (calcium-sensing receptor mutation), Sarcoidosis (ectopic 1-alpha-hydroxylase), and Osteomalacia (Vitamin D deficiency).

Correct matching requires evaluating serum calcium alongside serum phosphorus, intact PTH levels, and key clinical contextual clues to determine whether the metabolic abnormality is PTH-driven, PTH-independent, or a result of a defective receptor set-point.

Adım Adım Çözüm

Analyze patient 1's profile

High calcium, low phosphorus, low PTH, central lung mass.

Identifies PTH-independent hypercalcemia due to malignancy (PTHrP secretion mimicking PTH effects).

Analyze patient 2's profile

High calcium, low phosphorus, high PTH, kidney stones.

Identifies PTH-dependent hypercalcemia caused by primary hyperparathyroidism.

Analyze patient 3's profile

High calcium, normal PTH, highly restricted urine calcium.

Identifies an altered calcium sensing set point indicative of Familial Hypocalciuric Hypercalcemia (FHH).

Analyze patient 4's profile

High calcium, high-normal phosphorus, low PTH, signs of sarcoidosis.

Identifies 1,25-dihydroxyvitamin D-mediated hypercalcemia from granulomatous macrophage activity.

Analyze patient 5's profile

Low calcium, low phosphorus, very high PTH, high alkaline phosphatase.

Identifies secondary hyperparathyroidism in response to severe Vitamin D deficiency causing osteomalacia.

Anahtar Kavram

Differential diagnosis of calcium and bone metabolism disorders using paired serum calcium, phosphorus, and parathyroid hormone levels.

Soru 6Soru →

A 24-year-old woman with type 1 diabetes mellitus presents to the emergency department with abdominal pain, nausea, vomiting, and deep, rapid breathing. Vital signs show a heart rate of $118\text{ /min}$ and blood pressure of $90/60\text{ mmHg}$ . Laboratory studies show a blood glucose of $480 \text{ mg/dL}$ , an arterial pH of 7.15, positive serum ketones, and a serum potassium of $4.8 \text{ mEq/L}$ . Arrange the following management steps in the most appropriate chronological sequence for this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: 1) Administer an initial bolus of 0.9% normal saline, 2) Initiate continuous intravenous regular insulin infusion, 3) Add 5% dextrose to the intravenous maintenance fluids, 4) Transition to subcutaneous basal and bolus insulin.

The standard protocol for Diabetic Ketoacidosis (DKA) management requires a strict sequence of interventions based on patient safety and pathophysiology. The absolute first priority is intravascular volume repletion with 0.9% normal saline because patients are severely dehydrated from osmotic diuresis. Once volume expansion has begun and serum potassium is confirmed to be safely elevated (> 3.3 mEq/L), an intravenous regular insulin infusion is started to stop lipolysis and ketogenesis. As the insulin works, blood glucose typically drops faster than the ketoacidosis resolves. To prevent hypoglycemia while continuing the insulin necessary to close the anion gap, 5% dextrose is added to the IV fluids once the blood glucose reaches approximately 200 to 250 mg/dL. Finally, after the anion gap is closed, the acidosis has resolved, and the patient can eat, they are safely transitioned to a subcutaneous insulin regimen.

Adım Adım Çözüm

Recognize the diagnosis of diabetic ketoacidosis (DKA) and the immediate need for volume expansion.

Identify 0.9% normal saline bolus as the priority first step.

Patients with DKA are profoundly dehydrated due to osmotic diuresis, and restoring intravascular volume takes precedence over all other interventions.

Evaluate the serum potassium level to determine the safety of insulin therapy.

Identify that since potassium is 4.8 mEq/L, an intravenous insulin infusion can be started safely.

Insulin drives potassium into cells. Starting insulin without checking potassium (or if K+ < 3.3 mEq/L) can cause fatal hypokalemia. With a normal level, insulin is the immediate next step.

Determine the management approach for when blood glucose improves but the anion gap remains open.

Identify adding 5% dextrose to IV fluids as the subsequent step.

Glucose usually normalizes faster than the anion gap closes. Dextrose prevents hypoglycemia while allowing the insulin infusion to continue suppressing ketogenesis.

Identify the criteria for transitioning off the insulin infusion.

Select transitioning to subcutaneous insulin as the final step.

Once the anion gap closes (DKA resolved) and the patient can eat, they are transitioned to a standard subcutaneous insulin regimen.

Anahtar Kavram

The standard sequence of treatment for Diabetic Ketoacidosis (DKA) prioritizes aggressive volume resuscitation, followed by intravenous insulin (dependent on safe potassium levels), adding dextrose when glucose reaches 200 mg/dL, and finally transitioning to subcutaneous insulin upon resolution.

Tahmini Süre:1m 0s

Soru 7Soru →

A 54-year-old man is brought to the emergency department by his wife due to lethargy, severe nausea, vomiting, and abdominal pain that began 24 hours ago. Over the past year, he has experienced progressive fatigue, cold intolerance, erectile dysfunction, and decreased libido. Two weeks ago, he was evaluated by a new primary care physician who obtained the following laboratory results:

Test	Result	Reference Range
Thyroid-stimulating hormone (TSH)	1.6 mIU/L	0.5 - 5.0 mIU/L
Free thyroxine (T4)	0.5 ng/dL	0.9 - 1.7 ng/dL

Based on these results, the physician diagnosed hypothyroidism and initiated levothyroxine therapy.

On presentation today, his temperature is 36.8°C (98.2°F), blood pressure is 78/50 mm Hg, heart rate is 115/min, and respiratory rate is 18/min. Physical examination reveals a lethargic man with pale skin and dry mucous membranes. There is no hyperpigmentation of the palmar creases or oral mucosa. Visual field testing by confrontation is normal.

Current laboratory results:

Test	Result
Sodium	128 mEq/L
Potassium	4.2 mEq/L
Chloride	95 mEq/L
Bicarbonate	22 mEq/L
Blood urea nitrogen	32 mg/dL
Creatinine	1.4 mg/dL
Glucose	52 mg/dL

Which of the following best explains the pathophysiologic mechanism of this patient's acute decompensation?

Accelerated hepatic clearance of endogenous glucocorticoids

Concurrent autoimmune destruction of the adrenal cortex

Inadequate renal synthesis of renin leading to aldosterone deficiency

Sudden hemorrhage and infarction of a preexisting pituitary macroadenoma

Excessive exogenous thyroxine causing high-output cardiac failure

Cevabı ve açıklamayı göster

Cevap: Accelerated hepatic clearance of endogenous glucocorticoids

Cevap

Accelerated hepatic clearance of endogenous glucocorticoids

The correct answer is accelerated hepatic clearance of endogenous glucocorticoids. This patient's initial laboratory results (low free T4 with a normal TSH) indicate central (secondary) hypothyroidism. Combined with his history of erectile dysfunction and decreased libido, this points to broader panhypopituitarism, which frequently includes central adrenal insufficiency (ACTH deficiency). When levothyroxine is administered to a patient with untreated adrenal insufficiency, it increases the basal metabolic rate and upregulates hepatic enzymes responsible for cortisol metabolism. This accelerated clearance of the patient's already marginal endogenous cortisol stores rapidly precipitates an acute adrenal crisis, characterized by hypotension, hypoglycemia, and hyponatremia. For this reason, glucocorticoid replacement must always precede or accompany thyroid hormone replacement in patients with suspected panhypopituitarism.

Adım Adım Çözüm

Interpret the initial thyroid function tests to determine the etiology of hypothyroidism.

The patient has a low free T4 with an inappropriately normal TSH, indicating central (secondary) hypothyroidism, rather than primary hypothyroidism.

A properly functioning pituitary gland should produce an elevated TSH in response to low circulating free T4.

Correlate the central hypothyroidism with the patient's clinical symptoms.

The history of erectile dysfunction and decreased libido suggests concurrent hypogonadotropic hypogonadism. This points toward broader panhypopituitarism, which likely includes secondary adrenal insufficiency.

Multiple pituitary axis deficiencies often occur together, typically due to a pituitary mass or infiltrative disease.

Identify the etiology of the current acute presentation based on vital signs and metabolic derangements.

The patient is in distributive shock with hypoglycemia and hyponatremia (but normal potassium), which is a classic presentation of acute secondary adrenal crisis.

Glucocorticoid deficiency impairs vascular tone and hepatic gluconeogenesis. Normal potassium differentiates secondary from primary adrenal insufficiency.

Determine the pharmacological trigger for the acute crisis.

The initiation of levothyroxine increased his basal metabolic rate, accelerating the hepatic clearance of cortisol and tipping him into a severe acute cortisol deficit.

Thyroid hormone upregulates hepatic enzymes responsible for glucocorticoid metabolism. In patients with panhypopituitarism, glucocorticoid replacement must always precede thyroid hormone replacement.

Anahtar Kavram

Initiation of levothyroxine in a patient with undiagnosed panhypopituitarism (central hypothyroidism and central adrenal insufficiency) accelerates hepatic cortisol clearance and can precipitate a fatal acute adrenal crisis.

Tahmini Süre:2m 0s

Soru 8Soru →

Paramedics bring a $34$ -year-old female to the emergency department due to profound weakness, recurrent vomiting, and confusion. Her husband notes that she had been experiencing worsening fatigue, anorexia, and a $5$ -kg ( $11$ -lb) weight loss over the past four months. Three weeks ago, she was evaluated by a primary care provider. At that time, laboratory studies showed a thyroid-stimulating hormone (TSH) level of $14.2$ $\mu$ U/mL (normal: $0.4$ – $4.2$ $\mu$ U/mL) and a free thyroxine (T4) level of $0.7$ ng/dL (normal: $0.9$ – $1.7$ ng/dL). Her daily levothyroxine dose, which she has taken for Hashimoto thyroiditis for six years, was subsequently increased from $75$ $\mu$ g to $125$ $\mu$ g.

Today, her temperature is $37.8^\circ\text{C}$ ( $100.0^\circ\text{F}$ ), blood pressure is $78/46$ mm Hg, heart rate is $118$ /min, and respiratory rate is $22$ /min. Physical examination reveals generalized darkening of the skin, most prominent over the palmar creases and buccal mucosa.

Laboratory evaluation in the emergency department shows:

Laboratory Parameter	Result	Reference Range
Serum sodium	$128$ mEq/L	$136$ – $145$ mEq/L
Serum potassium	$5.8$ mEq/L	$3.5$ – $5.0$ mEq/L
Serum chloride	$96$ mEq/L	$95$ – $105$ mEq/L
Serum bicarbonate	$16$ mEq/L	$22$ – $28$ mEq/L
Blood urea nitrogen	$32$ mg/dL	$7$ – $18$ mg/dL
Serum creatinine	$1.4$ mg/dL	$0.6$ – $1.2$ mg/dL
Serum glucose	$54$ mg/dL	$70$ – $110$ mg/dL

Which of the following pathophysiologic mechanisms most likely precipitated this patient's acute deterioration?

Enhanced hepatic clearance of endogenous glucocorticoids

Profound intracellular triiodothyronine depletion

Ischemic necrosis of the anterior pituitary gland

Acute bilateral hemorrhagic infarction of the adrenal glands

Severe tissue resistance to circulating mineralocorticoids

Cevabı ve açıklamayı göster

Cevap: Enhanced hepatic clearance of endogenous glucocorticoids

Cevap

Enhanced hepatic clearance of endogenous glucocorticoids

The correct mechanism is enhanced hepatic clearance of endogenous glucocorticoids. This patient has Autoimmune Polyglandular Syndrome Type 2 (Hashimoto thyroiditis and Addison disease). Her insidious symptoms of weight loss and hyperpigmentation indicate chronic primary adrenal insufficiency. When her primary care provider carelessly increased her levothyroxine dose without evaluating for adrenal insufficiency, it precipitated an acute crisis. Thyroid hormone upregulates hepatic metabolism (specifically

11\beta

-hydroxysteroid dehydrogenase and ring-A reductases), which increases the clearance of cortisol. In an Addisonian patient whose adrenal glands cannot mount a compensatory increase in cortisol production, this rapid depletion of remaining cortisol stores leads to acute cardiovascular collapse, hyponatremia, hyperkalemia, and hypoglycemia.

Adım Adım Çözüm

Analyze the patient's underlying chronic symptoms and physical exam.

The patient has a 4-month history of fatigue, weight loss, and hyperpigmentation in the context of known Hashimoto thyroiditis.

This constellation of findings strongly suggests underlying chronic primary adrenal insufficiency (Addison disease) as part of Autoimmune Polyglandular Syndrome Type 2 (Schmidt syndrome).

Interpret the emergency department presentation and laboratory values.

The patient presents with distributive shock (hypotension, tachycardia), hyponatremia, hyperkalemia, non-anion gap metabolic acidosis, and hypoglycemia.

These are the classic hallmarks of an acute adrenal crisis, confirming the decompensation of her primary adrenal insufficiency.

Identify the precipitating event that caused the transition from chronic Addison disease to acute crisis.

Three weeks prior, her levothyroxine dose was significantly increased.

Inquiring about recent medication changes is crucial for determining the trigger of an acute endocrine decompensation.

Determine the pathophysiologic link between levothyroxine administration and adrenal crisis.

Thyroid hormone increases the basal metabolic rate, which includes upregulating the hepatic enzymes responsible for cortisol metabolism and clearance.

In a patient with failing adrenal glands who cannot increase cortisol synthesis, the enhanced clearance of their remaining trace cortisol rapidly induces profound glucocorticoid deficiency and shock.

Anahtar Kavram

Initiating or increasing thyroid hormone replacement in a patient with untreated adrenal insufficiency accelerates hepatic cortisol clearance, precipitating an acute adrenal crisis.

Soru 9Soru →

An intensive care unit team is evaluating a $68$ -year-old man who remains ventilator-dependent $18$ days after an emergency exploratory laparotomy and bowel resection for acute mesenteric ischemia. His prolonged hospitalization has been complicated by septic shock and ventilator-associated pneumonia. He is currently hemodynamically stable and off vasopressor support, but repeated attempts to wean him from mechanical ventilation have failed. His temperature is $37.4^\circ\text{C}$ ( $99.3^\circ\text{F}$ ), blood pressure is $118/76\text{ mm Hg}$ , and pulse is $88\text{/min}$ . Physical examination reveals generalized muscle wasting and diffuse anasarca. The thyroid gland is not palpable. As part of a comprehensive evaluation for the failure to wean, the following laboratory results are obtained:

Laboratory Test	Result	Reference Range
Thyroid-stimulating hormone (TSH)	$0.15\text{ mIU/L}$	$0.4 - 4.0\text{ mIU/L}$
Free T4	$0.6\text{ ng/dL}$	$0.9 - 1.7\text{ ng/dL}$
Total T3	$42\text{ ng/dL}$	$80 - 200\text{ ng/dL}$
Morning serum cortisol	$32\text{ \mu g/dL}$	$5 - 23\text{ \mu g/dL}$

Which of the following is the most appropriate next step in the management of this patient's endocrine findings?

Continue current supportive care without thyroid hormone supplementation

Initiate enteral levothyroxine replacement therapy

Initiate enteral methimazole therapy

Perform a radioactive iodine uptake scan

Measure serum thyroid peroxidase antibodies

Cevabı ve açıklamayı göster

Cevap: Continue current supportive care without thyroid hormone supplementation

Cevap

Continue current supportive care without thyroid hormone supplementation

The correct answer is to continue current supportive care without thyroid hormone supplementation. This patient's laboratory profile (low T3, low free T4, and low TSH) in the setting of severe, prolonged critical illness is classic for euthyroid sick syndrome (also known as nonthyroidal illness syndrome). This condition represents an adaptive physiologic response to severe systemic stress, characterized primarily by decreased peripheral conversion of T4 to active T3 (due to decreased 5'-deiodinase activity) and altered central TRH/TSH regulation. Thyroid hormone supplementation (such as levothyroxine or liothyronine) has not been shown to improve clinical outcomes, weaning from mechanical ventilation, or survival in these patients, and it may be harmful. The appropriate management is to treat the underlying illness; thyroid function typically normalizes upon recovery.

Adım Adım Çözüm

Evaluate the patient's clinical status and context.

The patient is in a state of severe, prolonged critical illness (postoperative shock, prolonged mechanical ventilation, generalized wasting).

Establishing the severity and acuity of the illness is critical for interpreting endocrine adaptations versus true pathology.

Analyze the thyroid laboratory panel in conjunction with the clinical context.

The panel shows low TSH, low free T4, and profoundly low total T3.

This specific pattern (especially the low T3 with variable T4 and TSH) is the hallmark of euthyroid sick syndrome, not primary or secondary hypothyroidism.

Evaluate the adrenal axis to rule out panhypopituitarism.

Morning serum cortisol is appropriately elevated (

32\text{ \mu g/dL}

) in the setting of severe stress.

A robust cortisol response effectively rules out central adrenal insufficiency, making true panhypopituitarism highly unlikely and confirming the thyroid labs are a standalone systemic adaptation.

Determine the evidence-based management strategy.

The plan should be observation and supportive care without exogenous thyroid hormones.

Clinical trials have consistently shown that supplementing thyroid hormone in euthyroid sick syndrome provides no benefit and may cause harm.

Anahtar Kavram

Euthyroid Sick Syndrome (Nonthyroidal Illness Syndrome)

Soru 10Soru →

Match the following serum calcium and intact parathyroid hormone (PTH) laboratory profiles to their most likely underlying pathophysiologic diagnosis.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

Elevated Ca/Elevated PTH matches Primary hyperparathyroidism. Decreased Ca/Elevated PTH matches Vitamin D deficiency. Elevated Ca/Suppressed PTH matches Humoral hypercalcemia of malignancy. Decreased Ca/Suppressed PTH matches Iatrogenic parathyroidectomy.

The parathyroid glands maintain calcium homeostasis through a direct negative feedback loop. Normal physiology dictates an inverse relationship: high calcium suppresses PTH, and low calcium stimulates PTH (secondary disorders). A direct relationship (both high or both low) indicates a primary parathyroid disorder.

Adım Adım Çözüm

Evaluate the serum calcium level in the provided profile.

Determines whether the clinical state is characterized by hypercalcemia or hypocalcemia.

Calcium is the primary regulated variable in this endocrine loop, driving the downstream hormonal response.

Evaluate the intact PTH level in the context of the calcium abnormality.

Identifies if the PTH response is appropriate (compensatory) or inappropriate (primary pathology).

An intact negative feedback loop will show PTH moving in the opposite direction of calcium. If PTH moves in the same direction, the parathyroid gland is the source of the pathology.

Anahtar Kavram

Calcium and Parathyroid Hormone (PTH) Homeostasis and Feedback Loop

Soru 11Soru →

A $45$ -year-old woman is evaluated in the clinic for a $4$ -month history of constant palpitations, excessive sweating, and a $6\text{-kg}$ ( $13.2\text{-lb}$ ) weight loss despite a significantly increased appetite. She also reports new, persistent bi-frontal headaches and recently sideswiped a vehicle while driving, stating she "did not see the car in the next lane." Physical examination reveals warm, moist skin, a fine resting tremor of the outstretched hands, and a diffusely enlarged, non-tender thyroid gland without palpable nodules. Confrontational visual field testing demonstrates diminished peripheral vision bilaterally. Vital signs show a heart rate of $110/\text{min}$ and blood pressure of $145/85\text{ mm Hg}$ . A urine pregnancy test is negative.

Laboratory results are as follows:
- Thyroid-stimulating hormone (TSH): $5.8\text{ mU/L}$ (Normal: $0.5\text{ - }5.0\text{ mU/L}$ )
- Free thyroxine (T4): $3.2\text{ ng/dL}$ (Normal: $0.9\text{ - }1.7\text{ ng/dL}$ )
- Free triiodothyronine (T3): $6.5\text{ pg/mL}$ (Normal: $2.0\text{ - }4.4\text{ pg/mL}$ )

Which of the following additional findings is most likely present in this patient?

Elevated serum alpha-subunit levels

Markedly decreased radioactive iodine uptake on thyroid scintigraphy

High titers of thyroid-stimulating immunoglobulins

A mutation in the thyroid hormone receptor beta (TR-beta) gene

Decreased synthesis of sex hormone-binding globulin (SHBG)

Cevabı ve açıklamayı göster

Cevap: Elevated serum alpha-subunit levels

Cevap

The most likely additional finding in this patient is elevated serum alpha-subunit levels.

The correct answer states that elevated serum alpha-subunit levels would be present. This patient presents with signs of clinical thyrotoxicosis (tremor, weight loss, excessive sweating, tachycardia, goiter) accompanied by symptoms of a sellar mass compressing the optic chiasm (headaches, bitemporal hemianopsia). The laboratory evaluation reveals elevated free T4 and T3 levels with an inappropriately unsuppressed (elevated) TSH. This pattern is defined as the syndrome of inappropriate TSH secretion. Given the clinical hyperthyroidism and central mass effect, the diagnosis is a TSH-secreting pituitary adenoma (TSH-oma). Because TSH shares a common alpha-subunit with luteinizing hormone, follicle-stimulating hormone, and human chorionic gonadotropin, TSH-omas classically co-secrete excess alpha-subunit, resulting in an elevated alpha-subunit-to-TSH molar ratio (often

>1.0

Adım Adım Çözüm

Evaluate the clinical presentation and physical examination findings.

The patient exhibits classic signs of thyrotoxicosis (weight loss, palpitations, tremor, heat intolerance, goiter) along with symptoms of a sellar mass compressing the optic chiasm (headaches, bitemporal hemianopsia).

Identifying both the systemic endocrine symptoms and localized neurologic symptoms is the first step in localizing the pathology.

Interpret the thyroid function tests in the context of the clinical picture.

The laboratory results show elevated free T4 and T3 levels with an inappropriately elevated TSH, defining the syndrome of inappropriate TSH secretion.

Normally, high free T4/T3 should suppress TSH to undetectable levels via negative feedback at the pituitary. An unsuppressed TSH indicates central dysregulation.

Differentiate between the causes of inappropriate TSH secretion.

The combination of clinical thyrotoxicosis and a compressive pituitary mass (bitemporal hemianopsia) points to a TSH-secreting pituitary adenoma (TSH-oma) rather than resistance to thyroid hormone.

Resistance to thyroid hormone typically presents with a clinically euthyroid or hypothyroid state due to peripheral resistance and lacks a pituitary mass.

Identify the expected biochemical markers for a TSH-secreting pituitary adenoma.

TSH-omas typically co-secrete the common alpha-subunit of pituitary glycoprotein hormones, leading to an elevated alpha-subunit-to-TSH molar ratio.

Confirming the secretory profile of pituitary adenomas is essential for definitive diagnosis.

Anahtar Kavram

Diagnosis of TSH-secreting pituitary adenoma (syndrome of inappropriate TSH secretion)

Tahmini Süre:1m 30s

Soru 12Soru →

A 45-year-old woman is being evaluated for progressive weight gain, proximal muscle weakness, and easy bruising. Physical examination reveals central adiposity, wide purple abdominal striae, facial plethora, and a blood pressure of 160/100 mmHg. The physician suspects Cushing syndrome. Assuming each step dictates the need for the subsequent one to identify an occult etiology, arrange the following diagnostic procedures in the correct sequential order, from initial confirmation to final localization.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence for evaluating Cushing syndrome is: 1) Confirm hypercortisolism with a screening test, 2) Measure morning ACTH, 3) Perform a pituitary MRI, and 4) Perform inferior petrosal sinus sampling (IPSS).

The evaluation of Cushing syndrome follows a strict stepwise approach to prevent misdiagnosis due to incidentalomas or physiological variations. First, hypercortisolism must be confirmed with screening tests (e.g., 24-hour urine free cortisol, low-dose dexamethasone suppression). Second, plasma ACTH is measured to classify the disease as ACTH-dependent or independent. Third, for ACTH-dependent disease, a pituitary MRI is obtained since Cushing disease is the most common etiology. Finally, if the MRI is inconclusive (e.g., lesion <6 mm or no lesion), inferior petrosal sinus sampling (IPSS) is performed to definitively differentiate between a pituitary and an ectopic ACTH source.

Adım Adım Çözüm

Confirm hypercortisolism

Pathologic cortisol excess is established

Avoids extensive testing in patients with physiologic stress or simple obesity

Measure morning ACTH

Determines ACTH dependence

Differentiates primary adrenal disease (suppressed ACTH) from pituitary or ectopic sources (normal/elevated ACTH)

Perform Pituitary MRI

Visualizes potential central source

Cushing disease (pituitary adenoma) is the most common ACTH-dependent cause and should be evaluated first

Perform IPSS

Definitively distinguishes pituitary from ectopic ACTH

Required when MRI does not show a clear >6 mm adenoma to accurately guide surgical intervention

Anahtar Kavram

The diagnostic algorithm for Cushing syndrome progresses sequentially from confirming hypercortisolism to determining ACTH dependence, followed by non-invasive imaging, and finally invasive localization if imaging is equivocal.

Soru 13Soru →

Match each patient's clinical presentation and laboratory evaluation to the most likely underlying diagnosis or pathophysiologic mechanism.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

Patient 1 matches autonomous adrenocortical cortisol hypersecretion. Patient 2 matches ACTH-secreting pituitary adenoma. Patient 3 matches paraneoplastic syndrome due to malignancy. Patient 4 matches suppression of the hypothalamic-pituitary-adrenal axis by exogenous agents.

The diagnostic workup for Cushing syndrome follows a rigorous stepwise approach. First, hypercortisolism is confirmed. Next, a plasma ACTH level determines if the cause is ACTH-independent (suppressed ACTH, typically adrenal) or ACTH-dependent (normal to high ACTH, typically pituitary or ectopic). For ACTH-dependent cases, a high-dose dexamethasone suppression test helps distinguish between a pituitary adenoma (which usually suppresses) and ectopic ACTH secretion (which typically does not suppress). Finally, exogenous glucocorticoids mimic Cushing syndrome clinically but suppress the entire HPA axis, resulting in undetectable ACTH and low endogenous cortisol.

Adım Adım Çözüm

Analyze the 24-hour urine free cortisol and morning serum cortisol levels to confirm the presence of endogenous hypercortisolism or hypocortisolism.

Patients 1, 2, and 3 have elevated urine free cortisol, confirming endogenous Cushing syndrome. Patient 4 has low morning cortisol despite physical signs of Cushing syndrome.

Establishing endogenous cortisol excess is the necessary first step in the algorithm to rule out physiological or iatrogenic variants.

Evaluate the plasma ACTH level to determine if the hypercortisolism is ACTH-dependent or ACTH-independent.

Patient 1 has suppressed ACTH (ACTH-independent). Patients 2 and 3 have normal/elevated ACTH (ACTH-dependent). Patient 4 has suppressed ACTH in the setting of low endogenous cortisol.

ACTH levels accurately differentiate primary adrenal causes from pituitary or ectopic causes.

Assess the response to the high-dose (8-mg) dexamethasone suppression test for the ACTH-dependent cases.

Patient 2 suppresses >50%, indicating a pituitary source (Cushing disease). Patient 3 does not suppress, indicating an ectopic ACTH source.

Pituitary adenomas generally retain a degree of negative feedback response to high-dose synthetic glucocorticoids, whereas ectopic tumors typically do not.

Anahtar Kavram

The diagnostic evaluation of Cushing syndrome relies on establishing hypercortisolism, differentiating ACTH-dependent from ACTH-independent causes via plasma ACTH levels, and utilizing the high-dose dexamethasone suppression test to locate the source of ACTH.

Tahmini Süre:2m 0s

Soru 14Soru →

Match each of the following clinical and laboratory profiles with the most likely pathophysiologic diagnosis.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

Each profile corresponds to a specific endocrine loop disturbance: Profile 1 to Primary adrenal insufficiency, Profile 2 to Secondary adrenal insufficiency, Profile 3 to Cushing disease, Profile 4 to Adrenal adenoma, and Profile 5 to Primary hyperaldosteronism.

Matching requires accurate identification of feedback loop disruptions. Primary defects show opposite directional changes in stimulating versus target hormones (e.g., high ACTH with low cortisol), whereas secondary defects show same-direction changes (e.g., low ACTH with low cortisol).

Adım Adım Çözüm

Analyze profiles with low cortisol to distinguish the level of the defect.

Low cortisol with high ACTH and hyperkalemia indicates primary adrenal failure, while low cortisol with low ACTH and normal potassium indicates secondary (pituitary) failure.

The intact aldosterone response (normal potassium) in central adrenal insufficiency differentiates it from primary disease.

Analyze profiles with hypercortisolism to identify the specific Cushing syndrome etiology.

High ACTH that suppresses with high-dose dexamethasone points to Cushing disease (pituitary), while undetectable ACTH without suppression indicates a primary adrenal tumor.

Pituitary adenomas retain partial feedback sensitivity to high-dose steroids, unlike adrenal tumors or ectopic ACTH sources.

Evaluate the profile with isolated mineralocorticoid abnormalities.

High aldosterone with low renin and normal cortisol confirms primary hyperaldosteronism.

Autonomous aldosterone secretion suppresses renin via volume expansion and operates independently of ACTH and cortisol.

Anahtar Kavram

Diagnosis of adrenal disorders relies on interpreting hormone pairs (e.g., ACTH and Cortisol, Renin and Aldosterone) to distinguish primary adrenal pathology from central (pituitary) defects.

Soru 15Soru →

A 54-year-old man presents to the clinic reporting a 4-month history of persistent fatigue, sluggishness, and increased sensitivity to cold. He also mentions a recent decline in his sexual drive and difficulty maintaining an erection. He has no past medical history and takes no medications. His temperature is $36.2^{\circ}\text{C}$ ( $97.2^{\circ}\text{F}$ ), blood pressure is $108/68\text{ mm Hg}$ , and pulse is $55\text{/min}$ . Physical examination demonstrates pale, dry skin and a noticeable delay in the relaxation phase of the patellar reflexes. Confrontational visual field testing detects a deficit in the temporal fields bilaterally.

Laboratory results are as follows:
Thyroid-stimulating hormone (TSH): $1.8\text{ }\mu\text{IU/mL}$ (normal: $0.4-4.0\text{ }\mu\text{IU/mL}$ )
Free thyroxine (T4): $0.5\text{ ng/dL}$ (normal: $0.9-1.7\text{ ng/dL}$ )
Total testosterone: $140\text{ ng/dL}$ (normal: $300-1,000\text{ ng/dL}$ )

Which of the following is the most likely underlying mechanism for this patient's findings?

Mass effect compressing the normal tissue within the sella turcica

Chronic lymphocytic infiltration of the thyroid stroma

Downregulation of peripheral 5'-deiodinase activity

Target tissue resistance to circulating thyroid hormones

Excessive production of biologically inactive thyroxine-binding globulin

Cevabı ve açıklamayı göster

Cevap: Mass effect compressing the normal tissue within the sella turcica

Cevap

Mass effect compressing the normal tissue within the sella turcica

The correct answer identifies a compressive pituitary mass (such as a nonfunctioning macroadenoma). The patient's clinical presentation includes symptoms of hypothyroidism (fatigue, cold intolerance, delayed reflexes) and hypogonadism (decreased libido, erectile dysfunction). Laboratory testing confirms low free T4 and low testosterone. Crucially, the TSH is inappropriately normal rather than elevated. In the setting of low target organ hormones, a lack of compensatory elevation in pituitary tropic hormones (TSH, LH/FSH) indicates central (secondary) failure. The combination of central hypothyroidism, central hypogonadism, and bitemporal hemianopsia (temporal visual field deficits) strongly suggests a mass in the sella turcica compressing both the normal anterior pituitary tissue and the overlying optic chiasm.

Adım Adım Çözüm

Analyze the patient's symptoms and physical examination findings.

The patient presents with symptoms of hypothyroidism (fatigue, cold intolerance, delayed reflexes), hypogonadism (decreased libido), and an optic chiasm lesion (bitemporal hemianopsia).

Identifying the clinical syndromes points toward a multiaxial endocrine defect combined with a structural neurologic deficit.

Evaluate the laboratory results, particularly the relationship between TSH and free T4.

Free T4 is low (

0.5\text{ ng/dL}

), but TSH is inappropriately normal (

1.8\text{ }\mu\text{IU/mL}

). Testosterone is also low.

A low free T4 with a normal TSH indicates central (secondary) hypothyroidism due to pituitary or hypothalamic dysfunction, distinguishing it from primary thyroid failure.

Synthesize the laboratory data with the physical exam findings to determine the underlying pathology.

The combination of central hypothyroidism, central hypogonadism, and bitemporal hemianopsia strongly indicates a compressive mass in the sella turcica, such as a pituitary macroadenoma.

A large pituitary mass can compress the optic chiasm above it and the normal anterior pituitary tissue around it, resulting in panhypopituitarism and visual field defects.

Anahtar Kavram

Diagnosis of central (secondary) hypothyroidism and panhypopituitarism due to a compressive sellar mass.

Tahmini Süre:1m 30s

Soru 16Soru →

A 42-year-old woman comes to the clinic reporting a 5-month history of worsening fatigue, a $4\text{ kg}$ ( $8.8\text{ lb}$ ) weight gain, and generalized weakness. She also notes that her menstrual periods have been absent for the past 6 months. Her last menstrual period was 7 months ago, and prior to this, her cycles were regular. She has no prior medical history and takes no medications. Vital signs show a pulse of $54 \text{ /min}$ and blood pressure of $100/60 \text{ mmHg}$ . Physical examination reveals pale, dry skin and delayed relaxation of the deep tendon reflexes. Visual field testing by confrontation is normal.

Laboratory studies show the following:

Test	Result	Reference Range
Thyroid-stimulating hormone (TSH)	$1.2 \text{ \mu U/mL}$	$0.4-4.2 \text{ \mu U/mL}$
Free thyroxine (T4)	$0.4 \text{ ng/dL}$	$0.9-1.7 \text{ ng/dL}$
Follicle-stimulating hormone (FSH)	$3 \text{ mIU/mL}$	$>30 \text{ mIU/mL}$ (postmenopausal)
Prolactin	$8 \text{ ng/mL}$	$4-23 \text{ ng/mL}$

Which of the following is the most likely explanation for this patient's clinical and laboratory findings?

Inadequate production of pituitary trophic hormones

Autoimmune destruction of multiple peripheral endocrine glands

Systemic down-regulation of basal metabolism due to severe illness

Increased hepatic synthesis of hormone-binding proteins

Peripheral receptor resistance to circulating endocrine hormones

Cevabı ve açıklamayı göster

Cevap: Inadequate production of pituitary trophic hormones

Cevap

Inadequate production of pituitary trophic hormones

This patient's clinical presentation and laboratory results confirm hypothyroidism (low free T4) and hypogonadism (amenorrhea). In a healthy hypothalamic-pituitary-target gland axis, a deficiency in peripheral hormones (T4, estrogen) removes negative feedback, prompting the pituitary to secrete high levels of trophic hormones (TSH, FSH) to stimulate the target glands. Therefore, primary glandular failure (like Hashimoto thyroiditis or premature ovarian failure) always presents with high TSH and high FSH. In this patient, both TSH and FSH are 'normal' or low, which is highly inappropriate for her degree of peripheral deficiency. This pattern definitively points to inadequate production of pituitary trophic hormones (central or secondary panhypopituitarism), which could be caused by a nonfunctioning pituitary macroadenoma, empty sella syndrome, or infiltrative disease.

Adım Adım Çözüm

Identify the primary clinical syndromes based on symptoms and physical exam.

The patient exhibits classic symptoms of hypothyroidism (fatigue, weight gain, bradycardia, delayed reflexes) and hypogonadism (secondary amenorrhea).

Recognizing the peripheral manifestations of endocrine deficiency directs the interpretation of the laboratory workup.

Evaluate the peripheral target gland hormone levels.

The free T4 level is definitively low (

0.4 \text{ ng/dL}

), confirming a hypothyroid state.

Biochemical confirmation of the clinical suspicion is required before assessing the regulatory axis.

Interpret the pituitary trophic hormone response to the low peripheral hormones.

Both TSH (

1.2 \text{ \mu U/mL}

) and FSH (

3 \text{ mIU/mL}

) are within normal or low ranges.

In a properly functioning hypothalamic-pituitary axis, low target hormones should eliminate negative feedback, resulting in elevated TSH and FSH.

Synthesize the findings to determine the anatomical site of the defect.

The combination of low peripheral hormones with inappropriately normal or low trophic hormones indicates that the pituitary gland is failing to secrete adequately.

This establishes a diagnosis of central (secondary) panhypopituitarism, differentiating it from primary target gland failure.

Anahtar Kavram

Diagnosis of secondary (central) hypothyroidism and hypogonadism relies on identifying low peripheral target gland hormones accompanied by inappropriately normal or low pituitary trophic hormones.

Soru 17Soru →

A 27-year-old woman, G1P0, at 7 weeks gestation presents to the clinic for her first prenatal visit. She reports mild morning nausea and breast tenderness but otherwise feels well. She was diagnosed with primary hypothyroidism secondary to Hashimoto thyroiditis 4 years ago and has been taking levothyroxine $100 \mu\text{g}$ daily since that time. Her pre-pregnancy thyroid function tests were consistently within normal limits. Her vital signs are stable, and physical examination shows a normal-sized, non-tender thyroid gland without nodules.

Laboratory evaluation reveals the following:

Laboratory Test	Result	Reference Range
Thyroid-stimulating hormone (TSH)	$5.2 \mu\text{U/mL}$	$0.1-2.5 \mu\text{U/mL}$ (1st trimester)
Total T4	$15.1 \mu\text{g/dL}$	$5.0-12.0 \mu\text{g/dL}$ (non-pregnant)

Which of the following is the most appropriate next step in the management of this patient's thyroid condition?

Increase the levothyroxine dose

Maintain the current levothyroxine dose

Decrease the levothyroxine dose

Switch from levothyroxine to propylthiouracil

Measure serum thyroid-stimulating immunoglobulins

Cevabı ve açıklamayı göster

Cevap: Increase the levothyroxine dose

Cevap

The most appropriate next step is to increase the levothyroxine dose.

This patient has an elevated TSH for her gestational age, indicating inadequately treated hypothyroidism. In a normal pregnancy, elevated estrogen levels increase the hepatic production and decrease the clearance of thyroxine-binding globulin (TBG). This physiological change requires the thyroid gland to increase total hormone production to saturate the additional TBG and maintain normal free T4 levels. Patients with primary hypothyroidism (e.g., Hashimoto thyroiditis) lack this reserve. Consequently, their free T4 falls and their TSH rises. To ensure adequate fetal neurodevelopment—which is entirely dependent on maternal thyroid hormone during the first trimester—the exogenous levothyroxine dose must typically be increased by approximately 20% to 30% as soon as pregnancy is confirmed. The elevated total T4 seen in this laboratory profile is an expected artifact reflecting the increased TBG-bound fraction, not clinical hyperthyroidism.

Adım Adım Çözüm

Interpret the thyroid-stimulating hormone (TSH) level in the context of the first trimester.

The TSH of

5.2 \mu\text{U/mL}

is significantly elevated above the strict first-trimester target range (

0.1-2.5 \mu\text{U/mL}

Pregnancy alters TSH reference ranges due to the stimulatory effect of hCG; elevated TSH indicates inadequate thyroid hormone replacement.

Analyze the elevated total T4 in the context of physiological pregnancy changes.

The total T4 is high purely due to estrogen-driven increases in thyroxine-binding globulin (TBG), which binds more T4, leaving less free T4 available.

Total T4 levels can be misleading during pregnancy; the elevated TSH confirms that physiologically active free T4 is insufficient.

Determine the therapeutic intervention required for a hypothyroid pregnant patient.

The levothyroxine dose must be increased (typically by about 30%).

Patients with pre-existing hypothyroidism lack the glandular reserve to intrinsically increase T4 production to saturate the new TBG and maintain adequate free hormone levels for fetal neurodevelopment.

Anahtar Kavram

Pregnancy induces an increase in estrogen, which stimulates hepatic production of thyroxine-binding globulin (TBG). Patients with pre-existing primary hypothyroidism cannot mount a compensatory increase in endogenous thyroid hormone to saturate this excess TBG, leading to reduced free T4 and elevated TSH. Consequently, levothyroxine doses typically must be increased by approximately 30% upon confirmation of pregnancy.

Tahmini Süre:1m 15s

Soru 18Soru →

An unresponsive 22-year-old male is brought to the emergency department by his parents. He has a history of type 1 diabetes mellitus but lost his insurance and ran out of his medication a week ago. Capillary blood glucose is $540\text{ mg/dL}$ . Vital signs show a blood pressure of $85/50\text{ mm Hg}$ , pulse of $128\text{/min}$ , and respirations of $28\text{/min}$ with deep, sighing breaths. Laboratory results reveal an arterial pH of $7.15$ , serum bicarbonate of $10\text{ mEq/L}$ , and serum potassium of $4.8\text{ mEq/L}$ . Urinalysis is strongly positive for ketones. Arrange the following management steps in the correct chronological sequence for the optimal treatment of this patient's acute condition.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence for managing this patient is: 1) Infuse isotonic (0.9%) saline intravenously, 2) Initiate a continuous intravenous regular insulin infusion, 3) Add 5% dextrose to the intravenous fluid regimen, and 4) Administer subcutaneous long-acting insulin.

The management of diabetic ketoacidosis follows a strict protocol to prevent severe complications. First, isotonic saline is given to restore volume in this hypotensive patient. Second, IV insulin is started (since potassium is safe at 4.8 mEq/L) to shut off lipolysis and resolve acidosis. Third, as glucose drops faster than ketones clear, dextrose must be added to IV fluids when glucose hits 200-250 mg/dL to prevent hypoglycemia while insulin continues. Finally, once the anion gap closes, subcutaneous insulin is given to provide overlap before the IV drip is stopped.

Adım Adım Çözüm

Administer aggressive intravenous fluid resuscitation with 0.9% saline.

Expands intravascular volume, stabilizes blood pressure, and improves renal perfusion.

The patient is hypotensive and profoundly dehydrated due to osmotic diuresis. Fluids must be given first to prevent cardiovascular collapse.

Start a continuous intravenous regular insulin infusion.

Suppresses ketone production and lowers blood glucose.

Insulin is required to correct the underlying metabolic acidosis, but it must be started after fluids and only when potassium is >3.3 mEq/L (his is 4.8 mEq/L).

Incorporate 5% dextrose into the IV fluids once glucose reaches 200-250 mg/dL.

Maintains blood glucose in a safe range while continuous insulin is administered.

The ketoacidosis takes longer to resolve than the hyperglycemia. Adding dextrose prevents iatrogenic hypoglycemia while the insulin drip continues to close the anion gap.

Transition to subcutaneous long-acting insulin.

Provides basal insulin coverage for maintenance.

Once the anion gap is closed and the patient can eat, subcutaneous insulin must be given 1-2 hours prior to stopping the IV drip to prevent rebound ketoacidosis.

Anahtar Kavram

The stepwise management of diabetic ketoacidosis (DKA) prioritizes volume resuscitation, followed by correction of acidosis with continuous insulin, prevention of hypoglycemia with dextrose, and finally transition to subcutaneous insulin.

Tahmini Süre:1m 30s

Soru 19Soru →

Match each classic physical examination finding to the endocrine condition with which it is most commonly associated.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

Pretibial myxedema pairs with Graves disease; the Chvostek sign pairs with Hypocalcemia; violaceous abdominal striae pair with Cushing syndrome; and hyperpigmentation pairs with Primary adrenal insufficiency.

Each physical finding is highly specific to its respective endocrine disorder's underlying pathophysiology. Pretibial myxedema is a localized autoimmune phenomenon unique to Graves disease. The Chvostek sign reflects the classic neuromuscular excitability seen in hypocalcemia. Violaceous striae arise from hypercortisolism-induced catabolism in Cushing syndrome. Diffuse hyperpigmentation is a direct result of elevated ACTH/MSH seen specifically in primary adrenal insufficiency.

Adım Adım Çözüm

Analyze the dermatologic finding of pretibial myxedema.

Identify it as a unique autoimmune manifestation.

It is mediated by TSH receptor antibodies stimulating dermal fibroblasts, uniquely linking it to Graves disease.

Evaluate the neuromuscular finding (Chvostek sign).

Identify it as a sign of membrane instability.

Low extracellular calcium directly increases the resting membrane potential of nerves, causing twitching upon mechanical stimulation.

Assess the origin of wide, violaceous striae.

Identify it as a sign of connective tissue breakdown.

Excess glucocorticoids (Cushing syndrome) weaken collagen and cause skin thinning, exposing underlying vascular beds.

Determine the cause of mucosal and palmar hyperpigmentation.

Identify it as a sign of elevated pro-opiomelanocortin (POMC) cleavage products.

Primary adrenal insufficiency lacks cortisol, resulting in high ACTH and MSH levels that stimulate melanocytes.

Anahtar Kavram

Classic physical examination findings and their associated endocrine disorders.

Soru 20Soru →

A 28-year-old woman comes to the clinic reporting profound fatigue, generalized weakness, and frequent dizzy spells over the past six months. She gave birth to her first child eight months ago. The delivery was complicated by severe uterine atony that required a massive blood transfusion and uterine artery embolization. She has not resumed menstruation and reports that she was completely unable to produce breast milk postpartum. The patient also notes recent cold intolerance and a 4-kg (8.8-lb) weight loss. Her blood pressure is 86/56 mmHg seated and 74/48 mmHg standing. Her heart rate is 92/min. Physical examination reveals delayed relaxation of deep tendon reflexes and a noticeable loss of pubic and axillary hair. Laboratory studies show:

Sodium: 133 mEq/L
Potassium: 4.2 mEq/L
Thyroid-stimulating hormone (TSH): 1.4 $\mu$ U/mL (Normal: 0.4–4.0 $\mu$ U/mL)
Free thyroxine (T4): 0.5 ng/dL (Normal: 0.9–1.7 ng/dL)

Which of the following is the most appropriate next step in the management of this patient?

Assess morning serum cortisol and adrenocorticotropic hormone levels

Initiate levothyroxine therapy immediately

Measure serum anti-thyroid peroxidase antibody titers

Prescribe oral fludrocortisone

Obtain a contrast-enhanced magnetic resonance imaging of the brain

Cevabı ve açıklamayı göster

Cevap: Assess morning serum cortisol and adrenocorticotropic hormone levels

Cevap

Assess morning serum cortisol and adrenocorticotropic hormone levels

The patient's clinical presentation (postpartum hemorrhage, failure to lactate, amenorrhea, hypotension) and laboratory findings (low free T4 with an inappropriately normal TSH) are classic for Sheehan syndrome (postpartum pituitary necrosis). This condition causes panhypopituitarism, meaning she likely has both central hypothyroidism and central adrenal insufficiency. A critical rule in endocrinology is that before initiating thyroid hormone replacement in any patient with suspected hypopituitarism, the adrenal axis must be evaluated (e.g., with 8 AM cortisol and ACTH). Initiating thyroid hormone increases the metabolic clearance of cortisol. If a patient has underlying, untreated adrenal insufficiency, giving levothyroxine will rapidly deplete their remaining cortisol, precipitating a life-threatening adrenal crisis.

Adım Adım Çözüm

Analyze the patient's history and symptoms.

The history of postpartum hemorrhage, failure to lactate, amenorrhea, and loss of pubic hair points toward panhypopituitarism (Sheehan syndrome).

Ischemic necrosis of the pituitary gland during complicated childbirth affects multiple endocrine axes, including prolactin, gonadotropins, TSH, and ACTH.

Interpret the laboratory findings.

A low Free T4 with an inappropriately normal TSH indicates central (secondary) hypothyroidism. The normal potassium level suggests the renin-angiotensin-aldosterone system is intact, characteristic of central adrenal insufficiency.

Primary hypothyroidism would feature an elevated TSH, whereas central hypothyroidism features a low or inappropriately normal TSH. Primary adrenal insufficiency would feature hyperkalemia, which is absent here.

Determine the appropriate management sequence.

The adrenal axis must be evaluated with a morning cortisol and ACTH level (or cosyntropin stimulation test) before initiating thyroid hormone.

Thyroid hormone increases the hepatic clearance of cortisol. Giving levothyroxine to a patient with untreated adrenal insufficiency can precipitate a lethal acute adrenal crisis.

Anahtar Kavram

In patients with suspected panhypopituitarism (e.g., central hypothyroidism), the adrenal axis must be evaluated and treated with glucocorticoids before initiating levothyroxine therapy to prevent an acute adrenal crisis.

Sayfa 1 / 21Sonraki

Endocrinology and Metabolism

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram